The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant chemotherapy in resectable gastric cancer: An international propensity-matched analysis of 23,805 patients from high-volume centers across three continents.
 
Max Hazeltine
Consulting or Advisory Role - LivsMed; Sovato
 
Ryuhei Aoyama
No Relationships to Disclose
 
Yongjia Yan
No Relationships to Disclose
 
Yoo Min Kim
No Relationships to Disclose
 
Andres Navarrette
No Relationships to Disclose
 
Ali Guner
No Relationships to Disclose
 
Eiji Tanaka
No Relationships to Disclose
 
Shizuki Sugita
No Relationships to Disclose
 
Alessandra Marano
No Relationships to Disclose
 
Shigeo Hisamori
Honoraria - Otsuka
 
Hiroshi Okabe
No Relationships to Disclose
 
Kazutaka Obama
Honoraria - Ethicon; Intuitive Surgical; Medtronic; Olympus; Otsuka
 
Yuman Fong
Stock and Other Ownership Interests - Imugene; Pfizer (I)
Consulting or Advisory Role - Imugene; Medtronic; Sangamo Bioscience; Sovato Health; Vergent Bioscience
Patents, Royalties, Other Intellectual Property - Viral Vector licensed to Imugene; Viral vector licensed to Merck
 
Woo Jin Hyung
Employment - Hutom
Leadership - Hutom
Stock and Other Ownership Interests - Hutom
Research Funding - GC Pharma; Medtronic
 
Yanghee Woo
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Ethicon; Imugene; Johnson & Johnson; Virtual Incision